Clinical Trials Logo

Hemodialysis Complication clinical trials

View clinical trials related to Hemodialysis Complication.

Filter by:

NCT ID: NCT03327909 Completed - Blood Pressure Clinical Trials

Timing of Antihypertensive Medications on Key Outcomes in Hemodialysis

TAKE-HOLD
Start date: July 16, 2018
Phase: N/A
Study type: Interventional

For patients with kidney failure requiring hemodialysis treatment, sometimes the blood pressure will drop too low during dialysis. In an effort to prevent that from occurring, patients are frequently told to skip doses of their blood pressure medications. However, whether this actually prevents blood pressure drops during dialysis, and whether it may cause more uncontrolled high blood pressure is unknown. TAKE-HOLD will study the effect of taking or holding blood pressure medication on blood pressure for patients on hemodialysis.

NCT ID: NCT03311581 Completed - Clinical trials for End Stage Renal Disease

The Feasibility of Propofol TCI in Hemodialysis Patients Undergoing Arteriovenous Shunt Surgery

Start date: September 11, 2017
Phase: Phase 1
Study type: Interventional

Written informed consent must be obtained before any study specific procedures are undertaken. Informed consent will be obtained during pre-operative assessment.

NCT ID: NCT03251573 Completed - Clinical trials for Cognitive Impairment

The Cohort Study of Cognitive Impairment in Chinese Hemodialysis Patients

CODE
Start date: September 1, 2017
Phase:
Study type: Observational [Patient Registry]

This study is going to apply neuropsychological battery tests to measure cognitive function across multiple cognitive domains in our cohort of 600 maintenance hemodialysis patients and evaluate: 1. The presence and patterns of cognitive impairment in domains of executive function, perceptual-motor function, language, learning and memory, and complex attention; 2. Clinical characteristics of participants with and without cognitive impairment; 3. the risk factors which might be related to cognitive impairment in this group of population; 4. The association between cognitive impairment and all-cause mortality, stroke and non-fatal cardiovascular events; We hypothesize that hemodialysis patient is going to have cognitive impairment which might be associated with some risk factors. We also anticipate that cognitive impairment might have some kind of association with the clinical outcomes like all-cause mortality, stroke and other common clinical outcomes that we mentioned above.

NCT ID: NCT03157050 Completed - Depression Clinical Trials

Intravenous Iron May Increase Depression Among Hemodialysis Patients

Start date: January 14, 2016
Phase: N/A
Study type: Observational

the aim of this study is to assess whether increased ferritin after intravenous iron therapy will lead to increased prevalence of major depression among treated patients.

NCT ID: NCT03149939 Completed - Hyperuricemia Clinical Trials

Use of Febuxostat in Hyperuricemia Among Hemodialysis Patients

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

Hyperuricemia is not infrequently encountered among hemodialysis patients. However, there is no clear data about use of febuxostat among hemodialysis patients, apart from very small case series. The aim of this study is to investigate the efficacy of using febuxostat for the treatment of Hyperuricemia among hemodialysis patients.

NCT ID: NCT03149874 Completed - Hepatitis B Clinical Trials

Accelerated Vaccination Schedule Against Hepatitis B Virus With Combined Hepatitis A and B Vaccine Among Hemodialysis Patients

Start date: December 1, 2014
Phase: N/A
Study type: Interventional

The aim of this study is to examine the result of seroprotection using the accelerated vaccination schedule in vaccination of hemodialysis patient through using combined hepatitis A and B vaccine.

NCT ID: NCT03144882 Completed - Clinical trials for Hemodialysis Complication

Evaluation of Curcumin's Effect on Inflammation in Hemodialysis Patients

Start date: February 2, 2015
Phase: N/A
Study type: Interventional

Programmed ingestion of turmeric has no adverse effects and reduces plasma level of hs-CRP, IL-6 and TNF-α accompanying with increases albumin levels in hemodialysis patients. Turmeric can be considered as an effective anti-inflammatory supplement in hemodialysis patients.

NCT ID: NCT03144817 Completed - Hypertension Clinical Trials

Dialysate Sodium Lowering Trial

DeSaLT
Start date: April 26, 2017
Phase: Phase 2
Study type: Interventional

This is a pilot randomized clinical trial in which patients treated with 3X per weekly conventional hemodialysis will be treated to a dialysate sodium 135 mEq/L vs. 138 mEq/L and followed for safety and tolerability, effects on BP and volume.

NCT ID: NCT03076528 Completed - Diabetes Clinical Trials

An Innovative Virtually Supervised Exercise for Dialysis Patients

Start date: November 6, 2016
Phase: Phase 2
Study type: Interventional

Among patients with diabetes 35% suffer from chronic renal disease and may require dialysis or kidney replacement over time. Furthermore, in diabetics with end stage renal disease (ESRD) that require dialysis, the risk of foot complications and amputation is even more common, expensive, and devastating. Interestingly, even though incidence of foot ulcers in patients with dialysis has been reported to be same as with patients with history of foot ulcers; dialysis patients have significantly higher rate of foot amputation. The goal of this research is to incorporate an innovative virtually supervised non-weight bearing exercise in patients undergoing dialysis to reduce risk of fall and foot ulceration by enhancing lower extremity blood flow, joint perception and joint mobility. Diabetic patients on hemodialysis at Hamad Medical Company will be recruited and will be randomized to either intervention (IG) or control (CG) group and followed for 6 months. The intervention group will take part in a 4-week non-weight bearing exercise program twice per week at the hemodialysis clinic under the supervision of a qualified research staff member. This intervention includes interactive game-based exercises including repetitive ankle and foot movements. Wearable sensors will provide real-time visual/auditory feedback from foot and ankle position and allowed perception of motor-errors during each motor-action. The control group will be instructed to complete a supervised foot and ankle exercise without using sensor technology. Changes in balance, gait, and physical activity, incidence of foot problems will be compared pre- and post-intervention. In addition, the incident of falls, foot ulcers, and limb amputation up to 6 months post intervention will be documented. Investigators hypothesize that patients receiving sensor-based exercises will benefit more compared to group receiving conventional non-technology training in terms of improving functional performance and reducing incidence of foot problems, falls, and limb amputation.

NCT ID: NCT03061552 Completed - Clinical trials for End Stage Renal Disease

Inferior Vena Cava Sonography in Hemodialysis Patients and Quality of Life

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

Determination of dry weight in patients with end-stage renal disease treated with hemodialysis is an unmet challenge in clinical nephrology. Current methods are imprecise, and thus many patients are hype- or hypovolemic, and suffer respective consequences such as hypertension, pulmonary congestion, cardiac hypertrophy, chronic dehydration, hypotension and shock. Several techniques have been proposed to asses hydration status in dialysis patient, among them measurement of bioimpedance and biochemical markers. Sonographic measurement of the inferior vena cava diameter (IVCD) is a method under investigation for assessing hydration status. It is available, inexpensive and efficient, yet operator-dependent. In a single-center, blinded and controlled trial it has been shown to improve clinical outcomes in patients receiving hemodialysis. In this study, we aim to assess the applicability and clinical utility of this method in our dialysis units. A crossover design is intended to examine the effect of IVCD measurement on quality of life and rate of hemodynamic adversities as compared with traditional estimation of dry weight.